Publicaciones en colaboración con investigadores/as de Royal Marsden Hospital (6)

2016

  1. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy

    European Journal of Cancer, Vol. 56, pp. 85-92

2015

  1. Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials

    The Lancet, Vol. 386, Núm. 10001, pp. 1353-1361

  2. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

    European Journal of Cancer

  3. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy

    Breast Cancer Research, Vol. 17, Núm. 1

2013

  1. Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

    The Lancet Oncology, Vol. 14, Núm. 1, pp. 88-96

2009

  1. A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 64, Núm. 6, pp. 1139-1148